Prospective trial of liposyn® 20% in patients undergoing bone marrow transplantation

Add time:07/19/2019    Source:sciencedirect.com

A study was undertaken of bone marrow transplant patients receiving parenteral nutrition containing an amino solution and either glucose alone or 25% or 60% of parenteral calories as Liposyn® 20% which compared the nitrogen balance, liver function tests and other biochemical and hematological variables. The nitrogen balance was equivalent in all of the study groups and there was no clinical or biochemical evidence of morbidity from any of the treatments. This study suggests that exogenously infused lipid is a suitable source of non-protein calories for bone marrow transplant patients.

We also recommend Trading Suppliers and Manufacturers of liposyn II (cas 112353-79-4). Pls Click Website Link as below: cas 112353-79-4 suppliers

Prev:Synthesis of N-acetyl-S-(3-coumarinyl)-cysteine methyl ester and HPLC analysis of urinary coumarin metabolites
Next:Reversal effect of riparin (cas 112356-54-4) IV in depression and anxiety caused by corticosterone chronic administration in mice)